Table 2 The SF-6D health utility scores (0-100) of Japanese patients with CH-C before, during and after treatment
LDV/SOF | LDV/SOF + RBV | SOF + RBV | p | |
|---|---|---|---|---|
Baseline | 76.4 ± 12.4 | 75.9 ± 10.3 | 76.1 ± 11.8 | 0.87 |
Treatment week 4 | 78.3 ± 12.1 | 75.5 ± 12.4 | 76.2 ± 13.0 | 0.10 |
Treatment week 8 | 78.8 ± 12.6* | 74.4 ± 11.4 | 75.5 ± 13.6 | 0.0023 |
Treatment week 12 | 79.2 ± 12.8* | 74.3 ± 12.5* | 75.7 ± 13.1 | 0.0012 |
Post-treatment week 4 | 78.4 ± 13.1* | 76.1 ± 13.3 | 77.4 ± 13.5 | 0.28 |
Post-treatment week 12 | 78.6 ± 13.0* | 76.7 ± 12.3 | 77.1 ± 14.0 | 0.36 |